Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOGC H Smorenburg, S M de Groot, A E van Leeuwen-Stok, et al.
The Netherlands Journal of Medicine|September 30, 2010
Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancerJ R Kroep, S C Linn, E Boven, et al.
Breast Cancer Research and Treatment|September 16, 2015
CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effectsV O Dezentjé, F L Opdam, H Gelderblom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancerG A P Hospers, M Schaapveld, J W R Nortier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 16, 2014
Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I studyL B J van Iersel, E M de Leede, A L Vahrmeijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2012
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patientsD B Y Fontein, D Houtsma, E T M Hille, et al.
Cancer|May 21, 2014
Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle studyNienke A de Glas, Duveken B Y Fontein, Esther Bastiaannet, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2018
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialM G M Derks, E Bastiaannet, W van de Water, et al.
Breast (Edinburgh, Scotland)|December 10, 2013
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' groupM E Hamaker, C Seynaeve, A N M Wymenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patientsL B J van Iersel, H Gelderblom, A L Vahrmeijer, et al.
Pageof 8